Shopping Cart 0
Cart Subtotal

Genomic Vision (GV) - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies



Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company's portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomic's technology finds application in monitoring both spatial and temporal characteristics of DNA replication in a single experiment and identification of structural variations at any position within the genome. It conducts research studies on large genomic rearrangements. Genomic is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Genomic Vision

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


Table Of Content


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Genomic Vision Company Overview 4

Genomic Vision Company Snapshot 4

Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview 4

Genomic Vision-Pipeline Analysis Overview 7

Genomic Vision-Key Facts 7

Genomic Vision-Major Products and Services 8

Genomic Vision Pipeline Products by Development Stage 9

Genomic Vision Ongoing Clinical Trials by Trial Status 11

Genomic Vision Pipeline Products Overview 13

BRCACombing Test 13

BRCACombing Test Product Overview 13

DNA Combing Based Test-Neurological Disorder 14

DNA Combing Based Test-Neurological Disorder Product Overview 14

FiberVision Automated Scanner 15

FiberVision Automated Scanner Product Overview 15

High-Throughput Scanner 16

High-Throughput Scanner Product Overview 16

HPV Combing Test 17

HPV Combing Test Product Overview 17

HPV Combing Test Clinical Trial 18

Lynch Syndrome Test 19

Lynch Syndrome Test Product Overview 19

Telomere Length Assay 20

Telomere Length Assay Product Overview 20

Genomic Vision-Key Competitors 21

Genomic Vision-Key Employees 22

Genomic Vision-Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Genomic Vision, Recent Developments 24

Apr 24, 2018: Genomic Vision Invited to Present FiberVision Platform at the NIST-FDA Genome Editing Workshop in Gaithersburg (Maryland) 24

Jan 17, 2018: Genomic Vision: 2017 Annual Revenue from Sales: +36% to EUR2.1 Million 24

Oct 24, 2017: Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to EUR1.3 Million 25

Oct 18, 2017: Genomic Vision: Report of the LSR R&D Day 26

Oct 11, 2017: Genomic Vision Presented the Interim Results of Its Clinical Trial in Cervical Cancer Screening at the Eurogin Annual Congress 26

Sep 11, 2017: Genomic Vision: High Attendance at the 1st US Satellite Symposium on Molecular Combing 27

Jul 27, 2017: Genomic Vision: Molecular Combing Featured in an Oral Presentation on CRISPR/Cas9 Gene Editing at the 3rd CSHL Meeting in New York 27

Jul 25, 2017: Genomic Vision: First half 2017 results 28

Jul 12, 2017: Genomic Vision: The Cologne Center for Genetics, a Major European Core Facility in Genetic Analysis, Adopts the Molecular Combing Technology 29

Jun 19, 2017: Genomic Vision Inks Chinese Distribution Deal with APG Bio 30

Appendix 31

Methodology 31

About GlobalData 33

Contact Us 33

Disclaimer 34

List Of Figure

List of Figures

Genomic Vision Pipeline Products by Equipment Type 5

Genomic Vision Pipeline Products by Development Stage 9

Genomic Vision Ongoing Clinical Trials by Trial Status 11

List Of Table

List of Tables

Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview 4

Genomic Vision Pipeline Products by Equipment Type 5

Genomic Vision Pipeline Products by Indication 6

Genomic Vision Ongoing Clinical Trials by Trial Status 6

Genomic Vision, Key Facts 7

Genomic Vision, Major Products and Services 8

Genomic Vision Number of Pipeline Products by Development Stage 9

Genomic Vision Pipeline Products Summary by Development Stage 10

Genomic Vision Ongoing Clinical Trials by Trial Status 11

Genomic Vision Ongoing Clinical Trials Summary 12

BRCACombing Test-Product Status 13

BRCACombing Test-Product Description 13

DNA Combing Based Test-Neurological Disorder-Product Status 14

DNA Combing Based Test-Neurological Disorder-Product Description 14

FiberVision Automated Scanner-Product Status 15

FiberVision Automated Scanner-Product Description 15

High-Throughput Scanner-Product Status 16

High-Throughput Scanner-Product Description 16

HPV Combing Test-Product Status 17

HPV Combing Test-Product Description 17

HPV Combing Test-Association Between High-risk HPV Genome Integration Detected by Molecular Combing and Cervical Lesions Severity and/or Evolution 18

HPV Combing Test-Integration of Oncogenic HPV DNA in Czech Republic 18

Lynch Syndrome Test-Product Status 19

Lynch Syndrome Test-Product Description 19

Telomere Length Assay-Product Status 20

Telomere Length Assay-Product Description 20

Genomic Vision, Key Employees 22

Glossary 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Genomic Vision, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Qiagen Marseille SA

Adocia SAS

Genfit SA

IntegraGen SA